You just read:

Eiger BioPharmaceuticals to Host Key Opinion Leader Event Addressing Need for Novel Mechanisms in the Treatment of Pulmonary Arterial Hypertension (PAH) on May 10th in New York City

News provided by

Eiger BioPharmaceuticals, Inc.

May 04, 2017, 08:00 ET